MAR 29, 2020 6:23 AM PDT

MicroRNA as a New Way to Test for Lung Cancer

WRITTEN BY: Jasper Cantrell

The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low mortality rate. Unfortunately, most symptoms appear only in the late stages, when mortality rates begin to increase dramatically. The most common treatment in current use is a CT test, or computer topography test, which brought down mortality rates by 20% when undergone by high-risk patients. A new test would be needed to try and catch lung cancer earlier.

One of the avenues that is being studied for such a diagnostic tool is looking at micro RNAs, or miRNA, in a patient’s blood. A miRNA is a small RNA strand around 20 nucleotides long. This RNA has been shown to regulate gene activity and to be quite stable. Due to its stability, it can even be measured in whole blood or plasma serum. Cancer regulates these miRNAs in a different way than normal, so it stood to reason that a diagnostic test might be able to utilize these in order to diagnose lung cancer. A group based out of Tokyo decided to conduct a comprehensive screen of patient plasma serum to see if they could identify a way to use miRNAs to diagnose lung cancer.

To begin, a large population of both cancer positive and non-cancer plasma serum was collected form the National Cancer Center Biobank, and the Yokohama Minoru Clinic in Japan. This population was then narrowed down, excluding those who previously had other cancers, lack of enough patient information, and other qualifiers. The ending populations were split into two groups, around 208 cancer, and 208 non-cancer serums in the discovery set. The rest, approximately 1400 cancer and 2000 non-cancer serums, were separated into a validation group.

Screening for 2588 miRNAs in the discovery group, 406 miRNAs were shown to be specific for the cancer group. From these, the group tried to identify miRNAs with high sensitivity and specificity. They identified three out of the 406. One miRNA, miR-17-3p, proved to be effective to a sensitivity of 93.5%, and a specificity of 88.5%. The other two, miR-1268b and miR-6075, had a sensitivity of 95% and near perfect specificity of 99% when acting as a pair.

Considering the miRNA pair gave the best results, it was tested for its ability to diagnose lung cancer patients with lung cancer at various stages. The group found that the pair had a performance above 90% at detecting lung cancer at every stage of progression. Unfortunately, all three miRNAs proved ineffective in detecting lung cancer in post-op patients.

Previous research had pointed out miRNAs as a possible diagnostic tool for various cancers, with all three primary hits from this paper appearing in other papers, as well as being linked to other cancers. This screen proved to have a much higher diagnostic accuracy by comparison to previous attempts, given its large sample size of both patients and miRNAs. The group concludes “The high sensitivity and specificity demonstrated by our results indicate the potential efficacy of this model in improving the early detection of resectable lung cancer, thereby reducing mortality and the use of unnecessary diagnostic procedures.”. Soon, this method might result in a quick and easy test for lung cancer, before it progresses into late stages, saving lives across the globe. 

Sources: Nature, Labroots
 

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
MAR 18, 2020
Cancer
MAR 18, 2020
Statins could reduce heart damage from breast cancer treatment
Cancer treatments have a lot of side effects. For breast cancer chemotherapies that use drugs like anthracycline an ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 10, 2020
Genetics & Genomics
MAY 10, 2020
Towards a Targeted Elimination of Leukemic Cells
Our blood carries many types of critical cells, including platelets, red blood cells, and white blood cells, which are m ...
MAY 05, 2020
Cancer
MAY 05, 2020
Can a face-aging app improve sun protection behavior?
Can a face-aging mobile app improve the skin cancer protection behavior of teenagers? A cluster-randomized clinical tria ...
MAY 18, 2020
Cancer
MAY 18, 2020
How do Ohnologs affect Cancer?
Genetics can be complicated to say the least. Sometimes it can be as simple as a single mutation in one gene that causes ...
Loading Comments...